Treatment with asthma medications in study patients
| SLTA(N = 30) | Controls(N = 60) | p value | OR (95% CI) | |
|---|---|---|---|---|
| Where data are not available for the complete group, numbers are given in parentheses. | ||||
| *Subjects not on fenoterol were on salbutamol except for one patient in the SLTA group who was using inhaled anticholinergic medication. | ||||
| No use of inhaled corticosteroid (%) | 43.3 (10/23) | 12.1 (7/58) | 0.003 | 5.6 (1.9 to 16.5) |
| Regular oral corticosteroid (%) | 16 (4/25) | 7 (4/57) | 0.22 | 2.5 (0.6 to 10.6) |
| β agonists (%) | ||||
| Inhaled fenoterol* | 68 (17/25) | 28.8 (17/59) | 0.0004 | 6 (2.2 to 16.2) |
| Theophylline (%) | 76 (19/25) | 56.7 | 0.09 | 1.8 (0.7 to 4.9) |
| Poor adherence with treatment (%) | 73 (22/30) | 51.7 (30/58) | 0.05 | 2.6 (1 to 6.6) |